CA1243604A - Facteur de croissance des cellules endotheliales - Google Patents

Facteur de croissance des cellules endotheliales

Info

Publication number
CA1243604A
CA1243604A CA000475304A CA475304A CA1243604A CA 1243604 A CA1243604 A CA 1243604A CA 000475304 A CA000475304 A CA 000475304A CA 475304 A CA475304 A CA 475304A CA 1243604 A CA1243604 A CA 1243604A
Authority
CA
Canada
Prior art keywords
ecg
heparin
solution
crude
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000475304A
Other languages
English (en)
Inventor
Michael Klagsbrun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Application granted granted Critical
Publication of CA1243604A publication Critical patent/CA1243604A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA000475304A 1984-02-29 1985-02-27 Facteur de croissance des cellules endotheliales Expired CA1243604A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58460484A 1984-02-29 1984-02-29
US584,604 1984-02-29

Publications (1)

Publication Number Publication Date
CA1243604A true CA1243604A (fr) 1988-10-25

Family

ID=24338044

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000475304A Expired CA1243604A (fr) 1984-02-29 1985-02-27 Facteur de croissance des cellules endotheliales

Country Status (2)

Country Link
AU (1) AU569376B2 (fr)
CA (1) CA1243604A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136025A (en) * 1990-04-04 1992-08-04 California Biotechnology Inc. Method to purify basic fibroblast growth factor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049611B2 (fr) * 1980-10-02 1993-12-08 Hooper Trading Co. N.V. Facteur de croissance pour cellules T et son procédé de préparation
WO1984004924A1 (fr) * 1983-06-03 1984-12-20 Us Commerce Facteur de croissance purifie de transformation du type beta derive de thrombocytes et de placentas humains
EP0169016B2 (fr) * 1984-07-16 2004-04-28 Celtrix Pharmaceuticals, Inc. Facteur polypeptidique issu des os induisant le cartilage

Also Published As

Publication number Publication date
AU3920685A (en) 1985-09-05
AU569376B2 (en) 1988-01-28

Similar Documents

Publication Publication Date Title
Erickson et al. A six-armed oligomer isolated from cell surface fibronectin preparations
Engvall et al. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen
Connolly et al. Human vascular permeability factor: isolation from U937 cells
Liotta et al. Biosynthesis of precursor corticotropin/endorphin-, corticotropin-, alpha-melanotropin-, beta-lipotropin-, and beta-endorphin-like material by cultured neonatal rat hypothalamic neurons.
Moscatelli High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells
CA1210345A (fr) A.t.c.c.hb8209 et son anticorps monoclonal contre l'erythropoietine
Williams et al. Platelet-derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissociable.
Stamatoglou et al. Correlation between cell substrate attachment in vitro and cell surface heparan sulfate affinity for fibronectin and collagen.
CA1188244A (fr) Angiotropines des leucocytes et des tissus enflammes et methode de preparation
KR100234497B1 (ko) Tgf-베타 2 및 tgf-베타3의 대형 잠복 복합체
US5039794A (en) Tumor egress factor and processes for producing the same
US4558005A (en) Monoclonal anti-erythropoietin
US4882275A (en) Method of purifying endothelial cell growth factors using immobilized heparin
Breyer et al. The epidermal growth factor precursor isolated from murine kidney membranes. Chemical characterization and biological properties.
US4902782A (en) Isolation of fibroblast growth factor
CA1243604A (fr) Facteur de croissance des cellules endotheliales
WO1989010133A1 (fr) Inhibiteurs de cellules a tiges
Chen et al. Secretogranin I/chromogranin B is a heparin‐binding adhesive protein
Csejtey et al. Purification of human macrophage colony Stimulatingv factor (CSF-1) from medium conditioned by pancreatic carcinoma cells
JP3030312B2 (ja) 成熟肝実質細胞増殖因子（ｉ）
DiSorbo et al. Purification from human hepatoma cells of a 130-kDa membrane glycoprotein with properties of the heparin-binding growth factor receptor
US5235042A (en) Endothelial cell growth factor
US5281582A (en) Serum growth factor
JPH0635480B2 (ja) 肝実質細胞増殖因子
EP0434836B1 (fr) Procede de purification de tenascine

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 20051025